Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA4 | P22748 | 4/20 | 0.39 |
| ▸ | CA9 | Q16790 | 4/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1011987 | 0.92 | CA1 (0.35) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL5032600 | 0.91 | CA1 (0.38) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL62392 | 0.91 | CA1 (0.35) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL83681 | 0.88 | CA1 (0.44) | CA1CA2CA4CA9TAAR1 | |
| Sulfuric Acid SCHEMBL28700686 | 0.88 | CA1 (0.46) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL2587081 | 0.85 | CA1 (0.43) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL657861 | 0.84 | CA1 (0.40) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL366506 | 0.82 | CA1 (0.42) | CA1CA2CA4CA9TAAR1 | |
| Acetonitrile SCHEMBL28171050 | 0.81 | CA1 (0.40) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL28531207 | 0.81 | CA1 (0.43) | CA1CA2CA4CA9TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116287120-A | Preservation solution capable of being preserved at normal temperature and preserving nucleic acid DNA and RNA of human cells in saliva sample at high temperature of 60 ℃ and preparation method thereof | 江苏康为世纪生物科技股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-0263875-A4 | MULTIPLE CONTROL STANDARD FOR BLOOD ANALYSIS. | BIONOSTICS INC (US) | 1989-11-07 | — | — | EP | claimed |
| EP-0263875-A1 | MULTIPLE CONTROL STANDARD FOR BLOOD ANALYSIS. | BIONOSTICS INC (US) | 1988-04-20 | — | — | EP | claimed |
| WO-1987006343-A1 | MULTIPLE CONTROL STANDARD FOR BLOOD ANALYSIS | BIONOSTICS, INC. (US) | 1987-10-22 | — | — | WO | claimed |
| EP-4675276-A1 | METHOD FOR IMMUNOLOGICALLY MEASURING HEMOGLOBIN USING DEGLYCOSYLATED HAPTOGLOBIN | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2026-01-07 | — | — | EP | disclosed |
| CN-116287120-B | Preservation solution capable of being preserved at normal temperature and preserving nucleic acid DNA and RNA of human cells in saliva sample at high temperature of 60 ℃ and preparation method thereof | 江苏康为世纪生物科技股份有限公司 | 2025-10-31 | — | — | CN | disclosed |
| EP-3761030-B1 | METHOD FOR STABILIZING PROTEIN CONTAINED IN SAMPLE AND SOLUTION FOR STABILIZING PROTEIN CONTAINED IN SAMPLE | EIKEN CHEMICAL (JP) | 2025-04-30 | — | — | EP | disclosed |
| CN-119061004-B | Microbial flora nucleic acid DNA preservation solution for sputum sample | 北京市疾病预防控制中心 | 2025-02-14 | — | — | CN | disclosed |
| US-12215140-B2 | Method of stabilizing protein contained in specimen and solution for stabilizing protein contained in specimen | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 2025-02-04 | — | — | US | disclosed |
| CN-119061004-A | Microbial flora nucleic acid DNA preservation solution for sputum sample | 北京市疾病预防控制中心 | 2024-12-03 | — | — | CN | disclosed |
| CN-111788484-B | Method for stabilizing protein contained in sample, solution for stabilizing protein contained in sample | 荣研化学株式会社 | 2024-11-19 | — | — | CN | disclosed |
| WO-2024181457-A1 | METHOD FOR IMMUNOLOGICALLY MEASURING HEMOGLOBIN USING DEGLYCOSYLATED HAPTOGLOBIN | 栄研化学株式会社 | 2024-09-06 | — | — | WO | disclosed |
| EP-1009426-A4 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | UNIV COLUMBIA (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1009426-A1 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | The Trustees of Columbia University in the City of New York (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1999011283-A1 | METHOD FOR TREATING A SUBJECT SUFFERING FROM CONDITIONS ASSOCIATED WITH AN EXTRACELLULAR ZINC SPHINGOMYELINASE | THE TRUSTEES OF COLOMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0809700-A1 | PAPILLOMA VIRUS-LIKE PARTICLES, FUSION PROTEINS AND PROCESS FOR PRODUCING THE SAME | MediGene Aktiengesellschaft (DE) | 1997-12-03 | — | — | EP | disclosed |
| WO-1996011272-A2 | PAPILLOMA VIRUS-LIKE PARTICLES, FUSION PROTEINS AND PROCESS FOR PRODUCING THE SAME | MEDIGENE GESELLSCHAFT FÜR MOLEKULARBIOLOGISCHE DIAGNOSTIK, THERAPHIE UND TECHNOLOGIE MBH (DE) | 1996-04-18 | — | — | WO | disclosed |
| WO-1990000003-A1 | PURIFICATION AND CHARACTERIZATION OF AN ACETYL-COA HYDROLASE | THE GENERAL HOSPITAL CORPORATION (US) | 1990-01-11 | — | — | WO | disclosed |
| WO-1989005820-A1 | HIV-RELATED ANTIGENS AND ANTIBODIES | ARCH DEVELOPMENT CORPORATION (US) | 1989-06-29 | — | — | WO | disclosed |
| EP-0308704-A1 | Heterogeneous enzymimmunoassay | FUJI PHOTO FILM CO., LTD. (JP) | 1989-03-29 | — | — | EP | disclosed |